Thrombolytic Science Revenue

Biotechnology Research • Cambridge, Massachusetts, United States • 1-10 Employees

Thrombolytic Science revenue & valuation

Annual revenue	$5,255,643
Revenue per employee	$1,314,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$16,900,000
Total funding	$7,500,000

Key Contact at Thrombolytic Science

Alexis Wallace

President & Chief Executive Officer, co-founder & board member

Company overview

Headquarters	763D Concord Avenue, Cambridge, MA 02138, US
Phone number	+10122018
Website	tsillc.net
SIC	283
Keywords	Ami Therapeutics, Cardiovascular Therapeutics, Stroke Therapeutics
Founded	2006
Employees	1-10
Socials

Thrombolytic Science Email Formats

Thrombolytic Science uses 1 email format. The most common is {first initial}{last name} (e.g., jdoe@tsillc.net), used 100% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@tsillc.net	100%

About Thrombolytic Science

TSI is a privately-held vascular medicine and biotechnology company currently developing a new-generation clot-dissolving therapy with the first novel mechanism of action in 20 years for stroke and other thrombotic diseases. TSI’s technology is based upon pioneering earlier work on pro-urokinase (proUK) by its cofounders. The primary component of TSI’s thrombolytic therapy is a rationally designed mutant of proUK.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Founder/Owner

Employees by Department

Thrombolytic Science has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Explore Thrombolytic Science's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2012-02-12	1	$7,500,000

Funding Insights

$7,500,000

Total funding amount

$7,500,000

Most recent funding amount

Number of funding rounds

Thrombolytic Science Tech Stack

Discover the technologies and tools that power Thrombolytic Science's digital infrastructure, from frameworks to analytics platforms.

Lodash

JavaScript libraries

Sentry

Issue trackers

Sirvoy

Appointment scheduling

Wix

Blogs

HTTP/3

Miscellaneous

HSTS

Security

Open Graph

Miscellaneous

React

JavaScript frameworks

Google Cloud

IaaS

Google Cloud CDN

CDN

Priority Hints

Performance

Microsoft 365

Frequently asked questions

Thrombolytic Science is located in Cambridge, Massachusetts, US.

You can reach Thrombolytic Science at +10122018.

Thrombolytic Science generates an estimated annual revenue of $5,255,643. This revenue figure reflects the company's market position and business performance in its industry.

Thrombolytic Science has an estimated valuation of $16,900,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Thrombolytic Science was founded in 2006, making it 20 years old. The company has established itself as a significant player in its industry over this time.

Thrombolytic Science has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Thrombolytic Science has raised a total of $7,500,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at Thrombolytic Science

Alexis Wallace

President & Chief Executive Officer, co-founder & board member

4.8

40,000 users